Bio View (XTAE:BIOV) Short Percentage of Float

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XTAE:BIOV Bio View Ltd XTAE:BIOV
41 GF Score
Price ₪0.82
GF Value ₪1.71
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Bio View Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

XTAE:BIOV vs ABT, SYK, MDT: Short Percentage of Float Comparison

For the Medical Devices subindustry, Bio View's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bio View Short Percentage of Float vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bio View's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Bio View's Short Percentage of Float falls into.


XTAE:BIOV
41GF Score
Bio View Ltd XTAE:BIOV
Short Percentage of Float is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Bio View (XTAE:BIOV) Overvalued in 2026?

Based on GuruFocus' analysis, Bio View stock appears to be undervalued. The current stock price of ₪0.82 is trading 52.3% below its estimated GF Value™ of ₪1.71. GuruFocus considers Bio View to be Possible Value Trap.

Key valuation signals for XTAE:BIOV:

  • Short Percentage of Float:
  • GF Value™: ₪1.71 vs. price of ₪0.82 (52.3% below fair value)
  • GF Score™: 41/100 with 5 warning signs

No single metric tells the full story. See the XTAE:BIOV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bio View Business Description

Address 3 Pekeris Street, Rehovot, ISR, 7670203
Bio View Ltd is an Israel based company engaged in the research, development, manufacture, marketing, and sale of computerized systems for identification of rate cells and test for detection of cancer. It manufactures and markets automated cell imaging and analysis solutions for use in cytology, cytogenetic, pathology clinical and research laboratories. Geographically, the group has its business presence in Israel, USA, and other countries, of which majority of the revenue is derived from the USA.
41GF Score

Get the complete analysis for XTAE:BIOV

Short Percentage of Float is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₪0.82
Price
₪1.71
GF Value